Ardsley Advisory Partners »

Augmedix shares owned by Ardsley Advisory Partners

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Ardsley Advisory Partners from 13F filings

Historical chart of Ardsley Advisory Partners investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Ardsley Advisory Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Ardsley Advisory Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 525k 4.09

More positions owned by Ardsley Advisory Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Sunrun (RUN)
Celestica Sub Vtg Shs (CLS)
Sunopta (STKL)
Itron (ITRI)
Bioceres Crop Solutions Corp SHS (BIOX)
Hannon Armstrong (HASI)
Oscar Health Cl A (OSCR)
Fluor Corporation (FLR)
Ftai Aviation SHS (FTAI)
Aspen Aerogels (ASPN)
Pacira Pharmaceuticals (PCRX)
Sentinelone Cl A (S)
Ferroglobe SHS (GSM)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Ardsley Advisory Partners

Top funds holding Augmedix

Redmile Group
Samjo Management
Citadel Advisors
Perkins Capital Management
Vanguard Group
Balyasny Asset Management
Parkman Healthcare Partners
Millennium Management
Caption Management
Rhenman & Partners Asset Management AB
Russell Investments
G2 Investment Partners Management
Essex Investment Management
Ardsley Advisory Partners
American Financial Group

View all funds holding Augmedix